This website has been developed by Novo Nordisk UK to provide
  information to UK-based adult patients who have been prescribed
  Wegovy®.
 
 The information on this website does
  not replace the patient information leaflet, which you are advised to
  read in full. It is not intended as a substitute for clinical advice
  provided by your healthcare professional. Please contact your
  healthcare professional if you have any questions about your treatment
  and for clinical advice.
 
 To ensure you receive the
  information that meets your needs, please tell us who you are:
I am a member of the public based in the UK →
I am a healthcare professional or other relevant decision maker based in United Kingdom →
I am an adolescent patient aged 12–17 years old who has been prescribed Wegovy® or their carer →
Reporting side effects
  
     This medicine is subject to additional
  monitoring. This will allow quick identification of new safety
  information promptly. You can help by reporting any side effects you
  may get. See https://yellowcard.mhra.gov.uk/ for how to report
  side effects.
 
 If you get any side effects, talk to your
  doctor, pharmacist or nurse. This includes any possible side effects
  not listed in the package leaflet. You can also report side effects
  directly via the Yellow Card Scheme at 
https://yellowcard.mhra.gov.uk/. Side effects
  should also be reported to Novo Nordisk Limited (Telephone Novo
  Nordisk Customer Care Centre 0800 023 2573). Calls may be monitored
  for training purposes. By reporting side effects, you can help provide
  more information on the safety of this medicine.